To study the influence of endothelium derived relaxing factor/nitric oxide (EDNO) on renin gene expression, the effects of a 2-day treatment with the NOsynthase inhibitor nitro-L-arginine-methylester (L-NAME, 40 mg/kg twice a day) on plasma renin activity (PRA) and renal and adrenal renin m-RNA levels were examined in conscious rats with and without unilateral renal clips (0.2 ram). In sham-clipped animals L-NAME led to a decrease of PRA from 7.5 to 2.5 ng angiotensin I (ANGI) 9 h -1 9 m1-1 and to a 35% decrease of renal renin m-RNA levels. Unilateral renal artery clipping increased PRA to 35 and to 13 ng ANGI. h -1 9 m1-1 in vehicle and in L-NAME-treated rats, respectively. In the clipped kidneys renin m-RNA levels increased to 450% of control values in vehicle-treated animals and to 220% of control values in L-NAME-treated animals. In the contralaterals as opposed to clipped kidneys, renin m-RNA levels decreased to 16% and 50% of the control values in vehicle-and in L-NAME-treated animals, respectively. In the adrenal glands renin m-RNA levels were not significantly changed either by clipping of one renal artery or by treatment of animals with L-NAME. The NO-donor sodium nitroprusside (100 ~tM) was found to increase renin secretion and renin m-RNA levels in primary cultures of renal juxtaglomerular cells. These findings suggest that EDNO is involved in the control of the renin gene by the renal perfusion pressure.
Introduction
There is accumulating evidence that endothelium derived relaxing factor (EDRF), which is considered to be nitric oxide (NO), is a potent modulator of renin secreCorrespondence to: K. Schricker tion from the kidneys [1, 8, 11, 15, 16, 18, 23, 24, 27] , A potential physiological role of EDRF/NO (or EDNO) in the control of renin secretion is, moreover, suggested by the high level expression of NO-synthase in renal macula densa cells [14, 26, 28] , which are directly adjacent to juxtaglomerular (JG) cells which produce, store and release renin in a regulated fashion [9] . The precise effect of EDNO on renin secretion, however, is still a matter of controversy. Thus, there are on the one hand reports of data obtained with anaesthetized rats [24] and with renal slices [1, 27] suggesting that EDNO exerts an inhibitory effect on renin secretion. There are on the other hand findings obtained from conscious [18] and anaesthetized dogs [16] , isolated perfused rat kidneys [8, 15, 23] and from isolated renal JG cells [11] suggesting that EDNO is a potent stimulator of renin secretion. The studies with the dogs and the isolated rat kidneys, moreover, strongly suggest that EDNO is essentially involved in the enhancement of renin secretion in response to a fail in renal artery pressure, a phenomenon that is commonly referred to as to the "baroreceptor-control" of renin secretion.
Although the linkage between renin secretion, renin synthesis and renin gene expression on the level of JG cells is not well understood, there is evidence for a concordant control of renin secretion and renin m-RNA levels by renal perfusion pressure [13] . In view of the profound effects of EDNO on pressure-related renin secretion it appeared reasonable, therefore, to also consider a potential role of EDNO on renin gene expression in this context.
We have addressed this question by examining the effect of the NO-synthase inhibitor nitro-L-arginine methylester (L-NAME) on renin m-RNA levels in conscious rats with and without unilateral renal artery stenosis.
Our findings strongly suggest that EDNO is an activator of renin gene expression in the kidney and is involved in the baroreceptor-control of renin gene expression.
Materials and methods
Animals. Male Sprague Dawley rats weighing 180-220 g were used for the experiments. Animals had free access to normal food (Altromin) and tap water.
Time course of renal renin m-RNA levels after unilateral renal artery clipping.
A total of 16 animals were anaesthetized with methohexital (50 mg/kg) and the left kidney was exposed by an abdominal incision. Sterile silver clips (Degussa, Germany) with an inner diameter of 0.2 mm were then placed on the left renal arteries. After 1, 2, 5 and 10 days four rats each were killed by decapitation and kidneys were rapidly removed. Kidneys were weighed, cut in half and frozen in liquid nitrogen until extraction of total RNA for determination of preprorenin m-RNA.
L-NAME treatment of clipped and sham-clipped rats. A total of 24 animals were anaesthetized with methohexital (50 mg/kg) and the left kidney was exposed by an abdominal incision. In 12 animals sterile silver clips (Degussa) with an inner diameter of 0.2 mm were then placed on the left renal arteries. In 12 sham-clipped animals the left artery was touched only with forceps. The animals were awakened within 30 rain after the operation and the NOsynthase inhibitor L-NAME (40 mg/kg) or vehicle (0.9% NaC1) were applied by intraperitoneal injection, to achieve protracted action of the drug. For replacement of eliminated drug the injections of drugs were repeated at 12-h intervals during experiments. During this period systolic blood pressure and heart rate were determined with a BP recorder 8005 (Rhema, Hofheim, Germany) in the morning (2 h after previous application of drugs) and in the afternoon (8 h after previous application of drugs). Then, 48 h after operation the animals were killed by decapitation. Blood was collected from the carotid arteries for determination of PRA and both kidneys and adrenal glands were rapidly removed, kidneys weighed, cut in half and frozen in liquid nitrogen until extraction of total RNA for determination of preprorenin m-RNA.
Determination of preprorenin m-RNA. Total RNA was extracted from the kidneys which were stored at -70 ~ C, according to the protocol of Chomczynski [3] by homogenization in 10 ml of solution D [guanidine thiocyanate (4 M) containing 0.5% N-laurylsarcosinate, 10 mM EDTA, 25 mM sodium citrate and 700 mM fimercaptoethanol] with a polytron homogenizer. Sequentially, 1 ml of 2 M sodium acetate (pH 4), 10 ml phenol (water saturated) and 2 ml chloroform were added to the homogenate, with thorough mixing after addition of each reagent. After cooling on ice for 15 rain samples were centrifuged at 10,000 g for 15 rain at 4 ~ C. RNA in the supernatant was precipitated with an equal volume of isopropanol at -20 ~ C for at least 1 h. After centrigugation RNA pellets were resuspended in 0.5 ml of solution D, again precipitated with an equal volume of isopropanol at -20 ~ C and RNA pellets were finally dissolved in diethylpyrocarbonate-treated water and stored at -80 ~ C till further processing. Renin m-RNA was measured by RNase protection as described for erythropoietin [21] . A preprorenin cRNA-probe containing 296 base pairs (bp) of exon I and II, generated from a pGEM-4 vector carrying a PstI-KpnI restriction fragment of a rat preprorenin cDNA [2] , was generated by transcription with SP6 RNA polymerase (Amersham International, Amersham, UK). Transcripts were continuously labelled with [a32p]GTP (410 Ci/mmol; Amersham) and purified on a Sephadex G50 spun column. For hybridization total kidney RNA was dissolved in a buffer containing 80% formamide, 40 mM piperazine N, NCbis(2-ethane sulphonic acid), 400 mM NaC1, 1 mM EDTA (pH 8). RNA (20 gg) was hybridized in a total volume of 50 gl at 60~ for 12 h with 8.3• Bq radiolabelled renin probe. RNase digestion with RNase A and T1 was carried out at 20~ for 30 min and terminated by incubation with proteinase K (0.1 mg/ ml) and sodium dodecyl sulphate (SDS, 0.4%) at 37~ for 30 min.
Protected preprorenin m-RNA fragments were purified by phenol/chloroform extraction, ethanol precipitation and subsequent Determination of act& m-RNA. The abundance of rat cytoplasmatic fl-actin m-RNA in total RNA isolated from the kidneys was determined by an RNase protection assay exactly as described for preprorenin. An actin cRNA-probe containing the 76 nucleotide first exon and around 200 bp of the surrounding sequence was generated by transcription with SP6 polymerase from a pAM19 vector carrying an AvaUHindIII restriction fragment of actin cDNA [21] . For one assay 2.5 gg RNA was hybridized under the conditions described for the determination of renin m-RNA.
Densitometry of preprorenin m-RNA of adrenal glands. Levels of preprorenin m-RNA in adrenal glands were estimated by densitometry (elscript 400, Hirschmann, Unterhaching, Germany) of the autoradiographs, which were exposed for 2-3 weeks. On each gel 2 renin m-RNA standards, consisting of 2 and 0.5 gg pooled RNA extracted from 12 kidneys of 6 normal Sprague Dawley rats, were coanalysed and densitometric values related to the standard of 2 ~tg total RNA (Fig. 7) .
Determination ofPRA. PRA was determined utilizing a commercially available radioimmunoassay kit for angiotensin I (ANGI) (Sorin Biomedica, Dfisseldorf, Germany).
Experiments with primary cultures of mouse renal juxtaglomerular (JG) cells. JG cells were isolated as previously described [4] from the mouse strain C57B16, which expresses only the ten-1 gene. The isolated cells were cultured in 96-well plates exactly as described [4] . The cultures were incubated at 37 ~ C in a humidified atmosphere containing 5% COz in air. Experiments were performed after 20 h of primary culture. At this time the culture medium was removed and the cultures were washed once with culture medium. Fresh culture medium together with the drugs to be tested or their respective solvent controls were then added.
Determination of renin secretion. At the end of the experiments, supernatants were collected and centrifuged at 500-1,000g at room temperature to remove cellular debris. The supernatants were then stored at -20 ~ C for further processing. Cells were lysed by adding to each culture well 50 gl of phosphate-buffered saline (PBS) containing 0.1% Triton X-t00, and then shaking for 45 rain at room temperature. The lysed cells were stored at -20 ~ C for further processing.
Renin secretion rates were estimated from the appearance rate of renin activity in the culture medium. To minimize differences among different cell culture preparations, renin secretion rates were calculated as fractional release of total renin [i.e. renin activity released/(renin activity released + renin activity remaining in the cells)]. Renin activity was determined by its ability to generate ANGI from the plasma of bilaterally nephrectomized rats. ANGI was measured by radioimmunoassay (Sorin Biomedica).
Determination of renin m-RNA in the cultured cells. At the end of
the incubation experiments, cultured cells were placed on ice, the culture medium was removed and the cells were washed once with ice-cold PBS buffer. Then, the cells were lysed by adding 40 gl of an ice-cold buffer containing 2% Nonidet (NP 40), t0 mM Tris-HC1 (pH 8), 10 mM NaC1, 3 mM MgClz and 0.7% (vol/vol) mercaptoethanol to each culture well and shaking for 15 min at 4 ~ C. The cellular lysates of two culture wells were pooled for the determination of renin m-RNA. Cell nuclei were removed by centrifugation at 12,000 g and 4 ~ C for 3 rain. Of the cytoplasmic fraction 3 gl was immediately used for reverse transcription, the remaining part was stored at -20 ~ C for cellular protein measurement.
Renin m-RNA was measured using a reverse transcriptasepolymerase chain reaction method (RT-PCR) exactly as described recently [5] . In brief, a sense primer which spans the exon 6/exon 7 border of the renin gene, and antisense primer located on exon 8 were used, thus amplifying a 194-bp sequence. For quantification, an internal renin m-RNA standard (254 bp) was synthesized by inserting a 60-bp fragment into the normal renin m-RNA sequence amplified by the RT-PCR exactly as described [5] .
Reverse transcriptase reaction. A 10-lxl aliquot of an ice-cold solution containing 10 pmol of the antisense primer, I gg of yeast tRNA and 5 pg of the internal standard were added to 3 gl of the cytosolic fraction. Samples were heated 5 rain at 94 ~ C and then chilled on ice. Then, 10 gl of solution A were added and the samples incubated at 37 ~ C for 1 h. Solution A consisted of 22 gl of a 25 mM solution of desoxyribonucleotides, 45 gl of 5 • RT-buffer (supplied with the reverse transcriptase kit), 6 gl of the RNase inhibitor rRNasin (Promega), 9 gl of M-MLV Reverse transcriptase (Gibco-Bfl) and 20 gl of 0.1 M dithiothreitol. After incubation at 37 ~ C for t h, the reaction was stopped by heating the samples for 2 rain at 95 ~ C.
Poiymerase chain reaction. To Mannheim, Germany), 30 PCR cycles consisting of denaturation at 94~ (1 rain), annealing at 60~ (1 rain) and extension at 72 ~ C (30 s) were performed. PCR was completed by a final extension step of l0 rain at 72 ~ C. After PCR, the amplification products originating from renin mRNA or from the internal standard were separated by polyacrylamide gel electrophoresis. N,N'-Methylenebis-acrylamide was replaced by dihydroxyethylene-bis-acrylamide. The bands were excised, solubilized in 0.025 M periodic acid and radioactivity assessed in a r-counter. The radioactivity incorporated by renin mRNA was routinely related as a percentage to the radioactivity incorporated by the 5 pg of internal standard.
Statistics. ANOVA t-test was used for interindividual comparisons and student's paired t-test for intraindividual comparisons. P < 0.05 was considered significant. 
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Results
Renin gene expression was studied in male Sprague Dawley rats with either normal renal blood flow, or with unilateral reduction of blood flow induced by silver clips with an inner diameter of 0.2 mm. To find the time point of maximal stimulations of renal renin gene expression and renin secretion we first measured renin m-RNA levels in the stenosed and in the contralateral kidneys, as well as PRA levels 1, 2, 5 and 10 days after setting the clips. As shown in Fig. 2 , the unilateral reduction of renal blood flow caused an increase of renin m-RNA levels of the clipped kidneys, which reached a maximum (550% of basal level) 2 days after setting the clip and returned to control values within 10 days (Fig. 2) . In contralateral kidneys renin m-RNA levels were suppressed to about 30% of control values after 1 day and this reduction of renin m-RNA remained throughout the 10 days of the experiments (Fig. 2) . PRA levels paralleled the m,RNA levels in the stenosed kidneys. For further experiments studying the influence of EDNO we chose, therefore, a time interval of 48 h after setting the clips, when PRA levels and renin m-RNA levels in the clipped kidneys were maximally stimulated, while renin m-RNA levels in the contralateral kidneys were significantly suppressed.
To inhibit endogenous EDNO formation we used intraperitoneal injections of [.-NAME (40 mg/kg twice a day) which has been found to be a tolerable inhibitor of NO-synthase in vivo [22] . To assess possible side effects of EDNO inhibition with relevance for the control of the renin system, such as an increase of blood pressure [22] or reflex inhibition of sympathetic outflow, we measured arterial pressure and heart rates during the 2 days of L-NAME-(40 mg/kg, twice a day)-injected rats after 48 h. Data are means + SEM of 6 animals in each experimental group. * P < 0.05 treatment with L-NAME. As shown in Fig. 3 , L-NAME caused a significant increase of systolic blood pressure, but had no measurable effect on heart rate in animals with nonclipped kidneys. Clipping of one renal artery did not change heart rates, but led to an increase of systolic blood pressure in vehicle-injected animals (Fig, 3) . Again L-NAME did not change heart rates in this group of rats whilst the increase of blood pressure upon clipping of one renal artery was the same in vehicle-and in L-NAME-injected rats. Treatment with L-NAME led to a significant decrease of basal values for PRA from 8 + 1.2 ng A N G I . h -a . m l 1 (mean + S E M ; n = 6 ) to 2.8 + 0.65 ng A N G I . h -1 9 ml ~ (n = 6) (Fig. 4) . Clipping of the left renal arteries for 2 days increased PRA values to 35 _+ 5.4 ng ANGI 9 h -~ 9 m1-1 (n = 6) in vehicle-injected rats, and to 13 + 3.6 ng ANGI 9 h -~ 9 m1-1 (n = 6) in L-NAME-treated animals (Fig. 4) . Renin m-RNA levels in the kidneys and in the adrenal glands were analysed by RNase protection. RNase protection assays for renin m-RNA on total RNA were performed using a 296-bp antisense riboprobe of rat preprorenin m:RNA. Figure 5 (upper panel) shows a representative autoradiograph of such an RNase protection assay for the left and right kidneys isolated from nonclipped vehicle-injected, nonclipped L-NAME-treated, left-side clipped vehicle-injected and left-side clipped L-NAME-treated rats. For comparison and quantification 20 btg of an aliquot from a pool of total RNA isolated from 12 kidneys of 6 normal adult male rats was coanalysed on the gel as an external standard (St). It is evident from Fig. 5 that renin m-RNA was decreased in the kidneys from the L-NAME-treated nonclipped rat when compared with the nonclipped vehicle-injected animal. Left renal artery clipping led to a marked increase of renin m-RNA in the clipped kidney and to a suppression of renin m-RNA in the contralateral kidney in vehicle- injected rats. In the L-NAME-treated animals the increases and suppression of renin m-RNA levels in the ipsilateral and contralateral kidneys, respectively, were markedly attenuated. For further quantification, protected fragments were excised from the dried gels and measured by assessing the fi radioactivity. After background subtraction the radioactivity of each band was related to that of the external standard RNA and expressed as a percentage of the standard. Average renin m-RNA levels that were quantified in this way for left and right kidneys isolated from the rats of the four experimental groups are summarized in Fig. 6 . In nonclipped animals there was no systematic side difference Number of animals is indicated in the bottom of bars of renin m-RNA levels between the two kidneys and L-NAME treatment led to a 35% decrease of basal renin m-RNA levels (Fig. 6, upper panel) . In vehicle-injected rats clipping of the left renal artery with a 0.2-ram clip increased renin m-RNA levels by 450% over the basal level in the clipped kidney and decreased m-RNA levels to 16% of the basal level in the contralateral right kidneys (Fig. 6, lower panel) . In L-NAME-treated animals renin m-RNA levels in the clipped kidney rose by 220% over the basal value of vehicle-injected rats and renin m-RNA levels in the contralateral kidneys decreased to 50% of the basal value. For control we also analysed the expression of a house-keeping gene such as fl-actin in vehicle-and L-NAME-treated rats. As illustrated in Besides the kidney, the adrenal gland has been recognized also as a relevant site of renin gene expression. We therefore analysed renin m-RNA levels in total RNA isolated from the adrenal glands of the L-NAME-treated and of vehicle-injected rats. Because of the rather low abundance of renin m-RNA in total RNA isolated from adrenal glands the long exposure time of the autoradiograph did not allow quantification of the protected fragments by assessing the /~ radioactivity. Therefore the bands on the autoradiograph were analysed by laser densitometry and the values obtained were given as a proportion of that obtained with 2 gg of the renal standard RNA which was coanalysed on each gel. To acertain linearity of densitometric evaluation, 0.5 gg of standard RNA were also coanalysed and given as a proportion of 2 Ixg of standard RNA (Fig. 7) . Adrenal renin m-RNA levels analysed by this way displayed a rather broad variance when compared with renal renin m-RNA levels. In sham-clipped vehicle-injected rats the abundance of renin m-RNA in adrenal glands was on average 2% of the value found for the kidneys. By ANOVA we found no difference of adrenal renin m-RNA levels between sham-clipped and clipped rats neither during vehicle nor during L-NAME injection. To examine the overall effect of L-NAME treatment on adrenal renin gene expression, therefore, we pooled the data for sham-clipped and clipped animals in both the vehicle and the L-NAME groups. As shown in Fig. 7 there was a tendency towards lower adrenal renin m-RNA levels in L-NAME-treated rats when compared with vehicle-injected animals. This difference, however, did not reach the level of statistical significance (P > 0.05).
The results described so far have not allowed distinction between direct and indirect effects of EDNO on renin secretion and renin gene expression. Therefore, we attempted to examine possible direct effects by examining the influence of the NO-donor nitroprusside on isolated renal JG cells. To this end, primary cultures of mouse renal JG cells were incubated with sodium nitroprusside (SNP, 100 gM) for 20 h and renin secretion was measured and cellular renin m-RNA levels were determined by RT-PCR as described recently [5] . For comparison we also examined the effects of the adenylate cyclase activator forskolin (10 ~tM), which has recently been shown to stimulate renin secretion and renin gene expression in isolated JG cells [5] . As shown in Fig. 8 (upper panel) SNP and forskolin produced comparable increases of renin secretion. Both drugs also led to significant (P < 0.01) increases of cellular renin m-RNA levels, with the difference that forskolin was more potent than SNP (Fig. 8, lower panel) . For control we also measured total RNA synthesis in the cultured cells by pulse experiments with [3H]uridine. In these experiments we found no effect of 100 ~tM SNP or 10 gM forskolin on total RNA synthesis.
Discussion
It was the aim of this study to examine the effect of EDNO on renin gene expression in the kidney under both basal conditions and under stimulation by a reduction of renal perfusion induced by unilateral 0.2-ram artery clips. In the presence of left renal artery clips renin m-RNA levels increased transiently in the clipped kidney with a time course which was similar to the timedependent changes of renin secretion found in experimental Goldblatt-hypertension [6] . In parallel, renin m-RNA levels were constantly suppressed in the contralateral kidney. Similar temporal patterns of renal renin m-RNA levels have already been described for unilateral renal artery clipping [12] and for aortic coarctation [13] .
Inhibition of endogenous EDNO formation was achieved with intraperitoneal injections of L-NAME, a well-established inhibitor of NO-synthase in vivo [22] . We found that administration of L-NAME to the conscious rats significantly decreased PRA and renal renin m-RNA levels under basal conditions, suggesting inhibition of basal renin secretion and of basal renal renin gene expression by L-NAME. Inhibition of endogenous EDNO formation has been reported to increase blood pressure [22] and to decrease heart rate [22] , which could suggest a reflex inhibition of sympathetic activity. Both reactions could in principle lead to a decrease of renin secretion and of renin gene expression, because blood pressure and renal nerve activity have been found to be activators of renin secretion and of renin gene expression [6, 12, 17, 29] . In our experiments we did not observe an effect of L-NAME on heart rate, which we considered as an indirect measure for sympathetic activity. Systolic blood pressure, however, increased significantly during treatment with L-NAME and, therefore, we can not definitively exclude the possibility from our experiments that the effects of L-NAME on basal PRA and on basal renal renin m-RNA levels were mediated by an increase of blood pressure. Changes of blood pressure or of sympathetic activity, however, are rather unlikely to account for the attenuation of renin secretion rates and renal renin m-RNA levels in animals with unilateral renal artery clips, because in those animals there were no differences in heart rates and in systolic blood pressures between the vehicle-and the L-NAME-treated animals. We infer, therefore, that the effects of L-NAME on the renin system in 2K-1C rats were primarily due to inhibition of intrarenal EDNO formation, rather than indirectly mediated by a side effect. This conclusion is supported by the previous findings that inhibitors of EDNO formation attenuate renal renin secretion in vitro in isolated perfused rat kidneys [8, 15, 23] and in cocultures of renal JG and endothelial cells [11] , as well as in vivo in dogs upon systemic and intrarenal application [16, 18] . Conversely, our findings now show that EDNO is a stimulator of renin secretion and of renin gene expression in renal JG cells (Fig. 8) . Thus, it appears likely that the in vivo effects of L-NAME are at least in part related to a direct stimulatory effect of EDNO on renal JG cells. In vivo experiments and experiments with isolated perfused rat kidneys have, moreover, produced evidence that the stimulation of renin secretion upon lowering the perfusion pressure is particularly sensitive to inhibition of endogenous EDNO production [18, 23] . Our data do confirm this notion and now provide the first evidence that the same holds for renin gene expression in the hypoperfused kidney. Thus, EDNO appears to be an activator of renal renin gene expression, and is involved in the control of the renin gene via the perfusion pressure. In this study we found that L-NAME attenuated the increases of renal m-RNA levels and of renin secretion in 2K-1C animals by about 50%. This value is close to the inhibition by L-NAME of renin release stimulated by low renal artery pressure in conscious dogs [18] . Intrarenal application of NO-synthase inhibitors in anaesthetized dogs [16] , or in isolated perfused kidneys, [23] has been found to decrease the renin secretion response to low perfusion pressure by 70-80%. It is not unlikely, therefore, in our experiments with conscious rats that EDNO production was not completely blocked, raising the possibility that a more effective inhibition of the NO system would further decrease renin gene expression in response to hypoperfusion of the kidney.
Interestingly, renin m-RNA levels in the contralaterals as opposed to the stenosed kidneys in L-NAMEtreated animals were not as strongly suppressed as in vehicle-injected rats. This may indicate that there was a minor release of factors that cause suppression of renin gene expression in contralaterals as opposed to stenosed kidneys. Although these factors have not yet been unequivocally characterized, angiotensin II (ANGII) is considered to be a likely candidate [20] . Our findings would not disagree with this concept, since L-NAME markedly suppressed renin secretion rates and thus the formation of systemic ANGII in the 2K-1C animals.
Besides the kidneys, the adrenal glands also have been recognized as a relevant site of renin gene expression. Moreover, it has been found recently that both renal and adrenal renin gene expression are stimulated by low salt intake [7, I0] , suggesting that adrenal and renal renin gene expression can in principle be regulated by common factors. This was the reason for us to also consider a possible influence of EDNO on adrenal renin gene expression. Indeed there was a tendency of adrenal renin m-RNA levels to decrease during L-NAME treatment, suggesting that EDNO might also be a stimulator of renin gene expression in adrenal glands. With 12 animals in each group, however, this effect did not reach statistical significance. It should be recalled in this context that the inhibitory effect of L-NAME on renal renin gene expression was also moderate under basal conditions and was more pronounced during stimulation by unilateral renal artery clipping, a manoeuvre which in turn had no effect on adrenal renin gene expression.
The question arises whether the stimulatory effect of EDNO on renin gene expression is like the effect of cAME a direct effect or one that is secondary to the stimulation of renin secretion by EDNO. In fact several possible modes of interdependent and independent controls of renin secretion and of renin synthesis have been previously reviewed [25] . Due to the poor understanding of the control of the renin gene on the level of JG cells, however, all of these models await further confirmation. Recently, we have found that in primary cultures of mouse renal JG cells the secretion and the synthesis of renin are not strictly linked [4] , suggesting that renin secretion and renin gene expression might be independently regulated from each other. In this view our present findings would suggest that EDNO is an activator of renin secretion and of renin gene expression in vitro and in vivo, which appears to be involved importantly in the control of renin gene expression by the renal perfusion pressure. A direct stimulatory effect of EDNO on transcriptional activity was in fact recently demonstrated for PC12 cells [19] . To examine the mechanisms along which EDNO could activate renin gene expression on the level of JG cells will be a task for our future work.
